Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Christina P. Borba, MPH
JCP
Original Research
Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics
April 16, 2007
David C. Henderson
,
Enrico Cagliero
,
Paul M. Copeland
, et al
JCP
Original Research
Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis
May 15, 2006
David C. Henderson
,
Paul M. Copeland
,
Christina P. Borba
, et al
JCP
Original Research
Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study
September 15, 2005
David C. Henderson
,
Dana D. Nguyen
,
Paul M. Copeland
, et al
JCP
Original Research
Risperidone Added to Clozapine: Impact on Serum Prolactin Levels
August 1, 2001
David C. Henderson
,
Donald C. Goff
,
Christine E. Connolly
, et al
JCP
Letter to the Editor
Citalopram and Clozapine: Potential Drug Interaction
September 30, 2000
Christina P. Borba
,
David C. Henderson
